The Maisonneuve-Rosemont Hospital will soon be home to a new $50 million cancer treatment centre.

The hospital, which is affiliated with the Université de Montréal, presented its draft plan to build the centre on Thursday.

The centre will specialize in immunotherapy, a relatively new method of treating cancer that is less invasive than chemotherapy and radiotherapy. Immunotherapy uses medications that cause a person's immune system to attack cancerous cells.

The centre received funding from both the federal and provincial government, as well as 40 private sector sponsors.

$800,000 for treatment in United States

The creation of the centre is welcome news for Laval resident Matthew Schreindorfer, who was diagnosed with leukemia in 2014.

He paid more than $800,000 for immunotherapy treatment in the United States. Afterwards, he was briefly declared cancer-free, but months later, doctors once again found cancerous cells in his bone marrow.

His friends and family crowdsourced the money for his treatment.

"We pushed a lot," he said. "We did a lot of awareness on Facebook and elsewhere. We're really happy to be here. This is excellent news for Montreal, Quebec and for Canada as a whole."

Quebec Health Minister Gaétan Barrette attended the hospital's announcement, and said he welcomes the centre.

"Understand that this centre is not only a production centre, but also a centre for research, processing and marketing," he said.